Kerry Wentworth insider trades

Open-market stock purchases and sales by Kerry Wentworth, CHIEF REGULATORY OFFICER at Nuvation Bio Inc, from SEC Form 4 filings since Jan 19, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +286%.

Recent trades

DateStockTradeValue
Jun 23, 2026NUVB Nuvation Bio IncSold$379K
Jun 23, 2026NUVB Nuvation Bio IncBought (not open market)—
Apr 17, 2026NUVB Nuvation Bio IncSold$184K
Apr 17, 2026NUVB Nuvation Bio IncBought (not open market)—
Apr 6, 2026NUVB Nuvation Bio IncSold$904K
Apr 6, 2026NUVB Nuvation Bio IncBought (not open market)—
Feb 27, 2026NUVB Nuvation Bio IncBought (not open market)—

Companies traded

  • NUVB Nuvation Bio Inc: 2 buys, 3 sales, last Jun 23, 2026
  • FLXN Flexion Therapeutics Inc: 3 sales, last Nov 19, 2021
  • AGEN Agenus Inc: 13 sales, last Feb 26, 2014

Get free alerts when Kerry Wentworth files a new trade →